Share Viking Therapeutics Trades 23% Below Its Own $35 Secondary Offering Price. Here's Why That Could Be a Gift for Patient Investors.

The Motley Fool · VKTX · November 4, 2026

Viking Therapeutics Trades 23% Below Its Own $35 Secondary Offering Price. Here's Why That Could Be a Gift for Patient Investors.

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: The Motley Fool ↗